Intrinsiqs

Is GSK plc overvalued?

GSK plc (GSK) looks undervalued — trading about 40% below its fair value.

Undervalued
Current price $47.03 Fair value $65.75
Price
$47.03
Fair value
$65.75
Current P/E
10.8
Normal P/E
15.1
Market cap
$94.22B
Dividend yield
3.7%
Return on equity
24.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares GSK's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 2 Oct 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.UNH UnitedHealth Group IncorporatedRHHBY Roche Holding AG